Volume 101, Issue 3 pp. 668-675
CASE REPORT

Transcatheter aortic valve replacement-related aortic dissection: A clinical case series

Takashi Hiruma MD

Takashi Hiruma MD

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan

Search for more papers by this author
Ryosuke Higuchi MD

Corresponding Author

Ryosuke Higuchi MD

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan

Correspondence Ryosuke Higuchi, MD, Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Fuchu, Tokyo 183-0003, Japan.

Email: [email protected]

Search for more papers by this author
Mike Saji MD, PhD

Mike Saji MD, PhD

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan

Search for more papers by this author
Itaru Takamisawa MD

Itaru Takamisawa MD

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan

Search for more papers by this author
Tomoki Shimokawa MD, PhD

Tomoki Shimokawa MD, PhD

Department of Cardiovascular Surgery, Sakakibara Heart Institute, Tokyo, Japan

Search for more papers by this author
Mamoru Nanasato MD, PhD

Mamoru Nanasato MD, PhD

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan

Search for more papers by this author
First published: 26 January 2023
Citations: 1

Abstract

Objectives

We review our experience with 13 periprocedural aortic dissection (AD) cases caused by transcatheter aortic valve replacement (TAVR).

Background

AD is a potentially lethal complication of TAVR; however, only sporadic case reports have been published to date.

Methods

Among 1335 consecutive patients who underwent TAVR in 2013–2021, we retrospectively extracted 13 patients (1.0%) with TAVR-related AD (Stanford type A in 6 [46%], type B in 7 [54%]). AD was defined as a new-onset dissected layer of the aortic wall and diagnosed by aortography, computed tomography, or transesophageal echocardiography.

Results

Five of the six type A AD cases (83%) were detected during TAVR versus only one of the seven type B AD cases (14%). Four of the seven type B AD cases (57%) were asymptomatic and incidentally detected on computed tomography. The presumed causes of AD were injury by the delivery sheath (39%), delivery catheter (23%), valve implantation (15%), stent edge (15%), and pre-dilation balloon (8%). Complicated AD occurred in only one patient (8%). Considering the patient's age and prohibitive surgical risk, all patients were treated conservatively and free of any aortic-related deaths or interventions during a follow-up of 1087 days.

Conclusions

TAVR-related AD is a rare but life-threatening condition that may be underdiagnosed. Its optimal therapy remains unclear, and conservative management might be an option for selected patients. Further studies are needed to elucidate the incidence, risk factors, effective screening, optimal therapy, and outcomes of TAVR-related AD.

DATA AVAILABILITY STATEMENT

Data cannot be made publicly available for ethical reasons, for example, public availability would compromise patient confidentiality.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.